|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
DE19845798A1
(de)
*
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
|
AU770381B2
(en)
*
|
1999-01-22 |
2004-02-19 |
Burnham Institute, The |
Homing pro-apoptotic conjugates and methods of using same
|
|
ES2311507T3
(es)
*
|
2000-02-10 |
2009-02-16 |
MASSACHUSETTS EYE & EAR INFIRMARY |
Terapia fotodinamica para tratamiento de afecciones oftalmicas.
|
|
AU2006203034B2
(en)
*
|
2000-02-10 |
2006-09-07 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
DE10043481A1
(de)
*
|
2000-09-04 |
2002-04-11 |
Vectron Therapeutics Ag Imt |
Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung
|
|
JP2003021631A
(ja)
*
|
2001-05-10 |
2003-01-24 |
Chugai Pharmaceut Co Ltd |
骨転移抑制剤のスクリーニング方法
|
|
US20030129193A1
(en)
*
|
2001-09-27 |
2003-07-10 |
Board Of Regents, The University Of Texas System And Peregrine Pharmaceuticals, Inc. |
Combined methods for tumor vasculature coaguligand treatment
|
|
AP2012006644A0
(en)
*
|
2003-08-01 |
2012-12-31 |
Genentech Inc |
Anti-VEGF antibodies
|
|
WO2005044853A2
(en)
*
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
EP1533617A1
(en)
*
|
2003-11-19 |
2005-05-25 |
RMF Dictagene S.A. |
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
|
|
US20060052286A1
(en)
*
|
2004-08-13 |
2006-03-09 |
Yale University |
Factor VII conjugates for selectively treating neovascularization disorders
|
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
|
JP5270161B2
(ja)
|
2004-09-24 |
2013-08-21 |
ベス イスラエル デアコネス メディカル センター |
妊娠合併症を診断および処置する方法
|
|
EP1839057B1
(en)
*
|
2004-12-15 |
2010-08-25 |
Beth Israel Deaconess Medical Center |
Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
|
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
|
EP2087001B1
(en)
|
2006-11-02 |
2016-10-26 |
Acceleron Pharma, Inc. |
Alk1 receptor and ligand antagonists and uses thereof
|
|
US8642031B2
(en)
|
2006-11-02 |
2014-02-04 |
Acceleron Pharma, Inc. |
Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
|
|
US10059756B2
(en)
|
2006-11-02 |
2018-08-28 |
Acceleron Pharma Inc. |
Compositions comprising ALK1-ECD protein
|
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗－ｖｅｇｆ抗體
|
|
CA2723449C
(en)
|
2008-05-02 |
2020-01-21 |
Acceleron Pharma Inc. |
Methods and compositions based on alk1 antagonists for modulating angiogenesis and pericyte coverage
|
|
US20100082438A1
(en)
*
|
2008-10-01 |
2010-04-01 |
Ronnie Jack Garmon |
Methods and systems for customer performance scoring
|
|
US8221753B2
(en)
|
2009-09-30 |
2012-07-17 |
Tracon Pharmaceuticals, Inc. |
Endoglin antibodies
|
|
KR101553740B1
(ko)
|
2009-08-17 |
2015-09-17 |
트라콘 파마수티칼즈, 인코포레이티드 |
항엔도글린 항체 및 항ｖｅｇｆ 제제를 사용한 암 치료를 위한 병용 요법
|
|
EP3144323A3
(en)
*
|
2009-12-09 |
2017-05-31 |
Bayer Pharma Aktiengesellschaft |
Anti-c4.4a antibodies and uses thereof
|
|
CN103619352A
(zh)
*
|
2011-02-23 |
2014-03-05 |
健康研究公司 |
抗内皮因子抗体和表达新人/鼠嵌合内皮因子的敲入小鼠
|
|
US9255595B2
(en)
*
|
2011-04-29 |
2016-02-09 |
Bae Systems Information And Electronic Systems Integration Inc. |
Optical dome bezel
|
|
UA115789C2
(uk)
|
2012-09-05 |
2017-12-26 |
Трейкон Фармасутікалз, Інк. |
Композиція антитіла до cd105 та її застосування
|
|
ES2710203T3
(es)
|
2013-06-14 |
2019-04-23 |
Agilent Technologies Inc |
Sistema y método para facilitar la clasificación manual de objetos
|
|
GB201402006D0
(en)
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
WO2016077451A1
(en)
|
2014-11-12 |
2016-05-19 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
US9926375B2
(en)
|
2014-11-12 |
2018-03-27 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
RU2763916C2
(ru)
|
2015-09-23 |
2022-01-11 |
Дженентек, Инк. |
Оптимизированные варианты анти-vegf антител
|
|
RU2607029C1
(ru)
*
|
2015-10-20 |
2017-01-10 |
ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ / ФГБУ "РНЦРХТ" Минздрава России |
ШТАММ ГИБРИДНЫХ КУЛЬТИВИРУЕМЫХ КЛЕТОК ЖИВОТНЫХ Mus musculus L. - EN-4C9 - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ПРОТИВ ЭНДОГЛИНА (CD105) ЧЕЛОВЕКА
|
|
CN106928359B
(zh)
*
|
2015-12-30 |
2020-10-13 |
广西医科大学 |
一种CD105纳米抗体Nb59
|
|
CN106928355B
(zh)
*
|
2015-12-30 |
2020-09-29 |
广西医科大学 |
一种CD105纳米抗体Nb184
|
|
GB2566221B
(en)
|
2016-06-24 |
2021-08-04 |
Univ South Carolina |
Inhibin as targetable regulators of angiogenesis
|
|
EP3900733A1
(en)
|
2020-04-24 |
2021-10-27 |
Derma Innovate S.L. |
Src kinase activators and eng function inhibitors as enhancers of skin homeostasis/regeneration and hair growth
|
|
CN116063496B
(zh)
*
|
2022-08-15 |
2023-10-24 |
营龄(武汉)生物科技有限公司 |
载药的人血白蛋白联合单克隆抗体在制备药物组合物中的用途
|
|
CN115991773B
(zh)
*
|
2022-08-15 |
2023-11-17 |
营龄(武汉)生物科技有限公司 |
一种含有人血白蛋白的药物组合物
|
|
WO2026017807A1
(en)
|
2024-07-18 |
2026-01-22 |
Beech Biotech Sa |
Compositions and uses thereof
|